Earnings Labs
Foghorn Therapeutics Inc. logo

Foghorn Therapeutics Inc. (FHTX)

NASDAQ·Healthcare·Biotechnology

$5.16

-0.96%

Mkt Cap $311.70M

Analyst Ratings

Buy

3

Hold

0

Sell

0

Price Target (9 analysts)

$11.67

Range $11.00$12.00

Implied Upside

+126.2%

Consensus $11.67 vs current $5.16